Supernus Pharmaceuticals (SUPN) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free SUPN Stock Alerts $30.83 +0.56 (+1.85%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investorsbusinesswire.com - May 2 at 11:00 AMINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investorsbusinesswire.com - May 1 at 8:17 PMBusy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Storyglobenewswire.com - May 1 at 8:00 AMSupernus Pharmaceuticals (SUPN) Scheduled to Post Quarterly Earnings on Wednesdaymarketbeat.com - May 1 at 7:41 AMThe Law Offices of Frank R. Cruz Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investorsbusinesswire.com - April 29 at 7:20 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPNprnewswire.com - April 28 at 10:15 AMLouisiana State Employees Retirement System Purchases New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - April 27 at 4:42 AMSupernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024globenewswire.com - April 24 at 4:05 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPNprnewswire.com - April 20 at 11:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPNstockhouse.com - April 20 at 2:02 AMNotable Two Hundred Day Moving Average Cross - SUPNnasdaq.com - April 19 at 8:55 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)markets.businessinsider.com - April 15 at 11:22 AMPhocas Financial Corp. Sells 35,507 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - April 15 at 8:20 AMSupernus receives FDA rejection for Parkinson's treatment, submits additional datauk.investing.com - April 10 at 2:23 AMUS FDA declines to approve Supernus' Parkinson's combination again (April 8)yahoo.com - April 9 at 4:12 PMSupernus Pharmaceuticals, Inc.: Supernus Provides Regulatory Update for SPN-830finanznachrichten.de - April 8 at 1:44 PMSupernus stock slides as FDA rejects Parkinson's disease infusion devicemsn.com - April 8 at 1:44 PMSupernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Diseasefinance.yahoo.com - April 8 at 1:44 PMSupernus Pharmaceuticals (NASDAQ:SUPN) Shares Gap Down to $33.55marketbeat.com - April 8 at 11:37 AMU.S. FDA declines to approve Supernus' drug-device combination for Parkinson's diseasereuters.com - April 8 at 8:44 AMSupernus Provides Regulatory Update for SPN-830globenewswire.com - April 8 at 8:00 AMAssenagon Asset Management S.A. Buys New Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - April 6 at 4:40 AMPadmanabh P. Bhatt Sells 14,491 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stockinsidertrades.com - March 26 at 4:32 AMSupernus Pharmaceuticals (NASDAQ:SUPN) Stock Price Down 3.9% Following Insider Sellingmarketbeat.com - March 25 at 6:39 PMSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) VP Sells $511,677.21 in Stockmarketbeat.com - March 25 at 6:24 PMSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) VP Padmanabh P. Bhatt Sells 12,364 Sharesinsidertrades.com - March 22 at 9:58 AMSupernus Pharmaceuticals, Inc.: Supernus Announces Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 21 at 3:57 AMSupernus Pharmaceuticals executive trades company stockinvesting.com - March 16 at 8:45 PMSUPN Apr 2024 29.000 callfinance.yahoo.com - March 16 at 10:13 AMPadmanabh P. Bhatt Sells 3,884 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stockinsidertrades.com - March 16 at 6:32 AMSupernus Pharmaceuticals executive sells over $2.1m in stockinvesting.com - March 15 at 7:01 PMSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Polar Capital Holdings Plcmarketbeat.com - March 11 at 1:50 PMSupernus to Participate in Two Upcoming Investor Conferencesglobenewswire.com - March 6 at 4:30 PMSupernus Pharmaceuticals: Moving Through An 'Inflection Year'seekingalpha.com - March 4 at 11:41 AMInvesco Ltd. Sells 64,791 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - March 3 at 5:22 AMSupernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 29 at 7:35 AMConnor Clark & Lunn Investment Management Ltd. Raises Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - February 29 at 6:48 AMSupernus to Participate in the TD Cowen 44th Annual Healthcare Conferenceglobenewswire.com - February 28 at 4:30 PMPiper Sandler Reaffirms Their Buy Rating on Supernus Pharmaceuticals (SUPN)markets.businessinsider.com - February 28 at 3:33 PMSupernus Pharmaceuticals (NASDAQ:SUPN) PT Lowered to $41.00marketbeat.com - February 28 at 11:14 AMSupernus Pharmaceuticals (NASDAQ:SUPN) Releases Earnings Results, Misses Estimates By $0.39 EPSmarketbeat.com - February 28 at 10:42 AMQ4 2023 Supernus Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 28 at 10:33 AMSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 10:33 AMStrong Buy for Supernus Pharmaceuticals on Qelbree’s Robust Sales Growth and Positive Market Outlookmarkets.businessinsider.com - February 28 at 5:32 AMRecap: Supernus Pharmaceuticals Q4 Earningsbenzinga.com - February 27 at 5:32 PMSupernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023finance.yahoo.com - February 27 at 5:32 PMSupernus Announces Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 27 at 4:05 PMEpoch Investment Partners Inc. Sells 88,386 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - February 26 at 8:30 AMRetirement Planning Co of New England Inc. Has $1.42 Million Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - February 21 at 3:33 PMState Board of Administration of Florida Retirement System Sells 31,877 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)marketbeat.com - February 19 at 5:23 AM Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. SUPN Media Mentions By Week SUPN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUPN News Sentiment▼0.000.42▲Average Medical News Sentiment SUPN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUPN Articles This Week▼53▲SUPN Articles Average Week Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PCRX News INVA News CORT News ARQT News OCUL News ORIC News PHAT News KPTI News BTAI News PRGO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SUPN) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsBiden Nomination CANCELED?The Freeport SocietyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
